Clinical trial
Safety Study of PLX4032 in Patients With Solid Tumors
NCT00405587 · Plexxikon, Industry · Completed
Key facts
| NCT number | NCT00405587 |
|---|---|
| Title | Safety Study of PLX4032 in Patients With Solid Tumors |
| Official title | A Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of PLX4032 in Patients With Solid Tumors |
| Lead sponsor | Plexxikon, Industry |
| Collaborators | Roche Pharma AG Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Malignant Melanoma, Colorectal Carcinoma |
| Intervention type | Drug |
| Interventions | PLX4032 |
| Enrollment | 109 |
| Start date | Nov 1, 2006 |
| Primary completion | Jul 1, 2015 |
| Completion | Feb 1, 2016 |
| First posted | Nov 30, 2006 |
| Last update posted | Aug 22, 2017 |
| Countries | Australia, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: